Literature DB >> 19169688

Successful twin pregnancy while on cyclophosphamide therapy in a patient with lupus nephritis.

Rajiva Gupta1, S Deepanjali, M M Thabah, P Kaur, S Gupta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19169688     DOI： 10.1007/s00296-009-0860-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  15 in total

1.  Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients.

Authors:  Du Le thi Huong; Zahir Amoura; Pierre Duhaut; Abdallah Sbai; Nathalie Costedoat; Bertrand Wechsler; Jean-Charles Piette
Journal:  J Rheumatol       Date:  2002-12       Impact factor: 4.666

2.  Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy.

Authors:  C C Mok; C S Lau; R W Wong
Journal:  Arthritis Rheum       Date:  1998-05

Review 3.  Drugs in pregnancy.

Authors:  G Koren; A Pastuszak; S Ito
Journal:  N Engl J Med       Date:  1998-04-16       Impact factor: 91.245

4.  Cyclophosphamide for lupus during pregnancy.

Authors:  M E B Clowse; L Magder; M Petri
Journal:  Lupus       Date:  2005       Impact factor: 2.911

5.  Cyclophosphamide therapy in a serious case of lupus nephritis during pregnancy.

Authors:  H Kart Köseoglu; A E Yücel; G Künefeci; F N Ozdemir; H Duran
Journal:  Lupus       Date:  2001       Impact factor: 2.911

Review 6.  Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype?

Authors:  G M Enns; E Roeder; R T Chan; Z Ali-Khan Catts; V A Cox; M Golabi
Journal:  Am J Med Genet       Date:  1999-09-17

Review 7.  Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide.

Authors:  G E Katsifis; A G Tzioufas
Journal:  Lupus       Date:  2004       Impact factor: 2.911

8.  Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy.

Authors:  D T Boumpas; H A Austin; E M Vaughan; C H Yarboro; J H Klippel; J E Balow
Journal:  Ann Intern Med       Date:  1993-09-01       Impact factor: 25.391

9.  Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus.

Authors:  C L Wang; F Wang; J J Bosco
Journal:  Lupus       Date:  1995-02       Impact factor: 2.911

10.  Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only.

Authors:  A D Steinberg; S C Steinberg
Journal:  Arthritis Rheum       Date:  1991-08
View more
  1 in total

Review 1.  Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.

Authors:  Maria Pia Amato; Emilio Portaccio
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.